1. Home
  2. AMKR vs GH Comparison

AMKR vs GH Comparison

Compare AMKR & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amkor Technology Inc.

AMKR

Amkor Technology Inc.

HOLD

Current Price

$51.29

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$111.39

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMKR
GH
Founded
1968
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
13.2B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
AMKR
GH
Price
$51.29
$111.39
Analyst Decision
Buy
Strong Buy
Analyst Count
9
21
Target Price
$42.00
$102.81
AVG Volume (30 Days)
4.2M
1.9M
Earning Date
02-09-2026
02-19-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
N/A
EPS
1.24
N/A
Revenue
$6,449,053,000.00
$902,569,000.00
Revenue This Year
$7.49
$35.01
Revenue Next Year
$9.04
$26.98
P/E Ratio
$40.92
N/A
Revenue Growth
0.14
30.38
52 Week Low
$14.03
$34.88
52 Week High
$55.17
$120.74

Technical Indicators

Market Signals
Indicator
AMKR
GH
Relative Strength Index (RSI) 59.41 54.28
Support Level $49.00 $113.02
Resistance Level $55.17 $120.74
Average True Range (ATR) 3.05 5.34
MACD -0.27 -0.08
Stochastic Oscillator 55.47 41.62

Price Performance

Historical Comparison
AMKR
GH

About AMKR Amkor Technology Inc.

Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: